BioCentury
ARTICLE | Clinical News

Lysodase PEG-glucocerebrosidase: Began Phase I trial

January 16, 1995 8:00 AM UTC

Enzon Inc. (ENZN), Piscataway, N.J. Product: Lysodase PEG- glucocerebrosidase Indication: Gaucher's disease, to correct the genetic lack of glucocerebrosidase Status: Began Phase I trial ...